X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (47) 47
humans (44) 44
hematology (34) 34
lymphomas (33) 33
female (28) 28
male (28) 28
aged (27) 27
middle aged (27) 27
prognosis (26) 26
adult (24) 24
oncology (21) 21
retrospective studies (20) 20
aged, 80 and over (19) 19
lymphoma (17) 17
survival (17) 17
cancer (15) 15
chemotherapy (15) 15
b-cell lymphoma (14) 14
adolescent (13) 13
patients (13) 13
young adult (13) 13
analysis (12) 12
disease (12) 12
lymphoma, large b-cell, diffuse - drug therapy (12) 12
medical research (11) 11
antineoplastic combined chemotherapy protocols - therapeutic use (10) 10
care and treatment (10) 10
cyclophosphamide (10) 10
lymphoma, large b-cell, diffuse - mortality (10) 10
survival analysis (10) 10
treatment outcome (10) 10
clinical medicine (9) 9
follow-up (9) 9
lymphocytes b (9) 9
relapse (9) 9
rituximab (9) 9
biomarkers (8) 8
classification (8) 8
neoplasm staging (8) 8
pet/ct (8) 8
positron-emission tomography (8) 8
tomography, x-ray computed (8) 8
diffuse large b-cell lymphoma (7) 7
elderly-patients (7) 7
gene expression (7) 7
hodgkin disease - pathology (7) 7
lymphoma, large b-cell, diffuse - pathology (7) 7
medicine (7) 7
pet imaging (7) 7
positron-emission-tomography (7) 7
tomography (7) 7
cyclophosphamide - therapeutic use (6) 6
denmark (6) 6
denmark - epidemiology (6) 6
diagnosis (6) 6
expression (6) 6
fdg-pet/ct (6) 6
fluorodeoxyglucose f18 (6) 6
klinisk medicin (6) 6
lymphoma, large b-cell, diffuse - diagnosis (6) 6
medical and health sciences (6) 6
medical prognosis (6) 6
medicin och hälsovetenskap (6) 6
medicine, experimental (6) 6
non-hodgkin-lymphoma (6) 6
positron emission (6) 6
positron emission tomography (6) 6
remission induction (6) 6
research (6) 6
survival rate (6) 6
transplantation (6) 6
antineoplastic combined chemotherapy protocols (5) 5
biology and life sciences (5) 5
cancer and oncology (5) 5
cancer och onkologi (5) 5
central nervous system (5) 5
chemotherapy plus rituximab (5) 5
disease-free survival (5) 5
gene expression profiling (5) 5
hemic and lymphatic diseases (5) 5
medicine and health sciences (5) 5
response criteria (5) 5
risk factors (5) 5
risk groups (5) 5
anthracyclines (4) 4
b cells (4) 4
chop (4) 4
clinical trials (4) 4
cohort studies (4) 4
diffuse large b‐cell lymphoma (4) 4
dlbcl (4) 4
doxorubicin (4) 4
doxorubicin - therapeutic use (4) 4
follicular lymphoma (4) 4
gene expression regulation, neoplastic (4) 4
hodgkin disease - diagnostic imaging (4) 4
hospitals (4) 4
journal article (4) 4
lymphoma, non-hodgkin - pathology (4) 4
lymphoma, non-hodgkin - therapy (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


British Journal of Haematology, ISSN 0007-1048, 08/2019, Volume 186, Issue 3, pp. 409 - 419
Journal Article
BMC Medical Research Methodology, ISSN 1471-2288, 01/2019, Volume 19, Issue 1, pp. 23 - 13
BackgroundWithin cancer care, dynamic evaluations of the loss in expectation of life provides useful information to patients as well as physicians. The loss of... 
Extrapolation | Loss of lifetime | Relative survival | Cancer survival | PROPORTIONAL-HAZARDS | TRIALS | EXPECTATION | HEALTH CARE SCIENCES & SERVICES | EXTRAPOLATING SURVIVAL | TIME | Analysis | Censorship | Lymphomas | Studies | Survival analysis | Accuracy | Mortality | Clinical trials | Cardiovascular disease | Cancer
Journal Article
Journal Article
American Journal of Hematology, ISSN 0361-8609, 11/2015, Volume 90, Issue 11, pp. 1041 - 1046
Journal Article
American Journal of Hematology, ISSN 0361-8609, 11/2015, Volume 90, Issue 11, pp. 975 - 980
According to the updated guidelines for imaging in lymphoma, 18F‐FDG positron emission tomography/computed tomography (PET/CT) is recommended for staging and... 
FDG-PET | POSITRON-EMISSION-TOMOGRAPHY | INTERNATIONAL WORKSHOP | F-18-FDG PET/CT | RESPONSE ASSESSMENT | NON-HODGKIN-LYMPHOMA | PROGRESSION-FREE | HEMATOLOGY | PROGNOSTIC VALUE | METABOLIC TUMOR VOLUME | CLINICAL-SIGNIFICANCE | Doxorubicin - therapeutic use | Liver - pathology | Prognosis | Humans | Middle Aged | Lymphoma, Large-Cell, Anaplastic - diagnostic imaging | Male | Tomography, X-Ray Computed | Lung - diagnostic imaging | Positron-Emission Tomography | Cyclophosphamide - therapeutic use | Lymphoma, T-Cell, Peripheral - diagnostic imaging | Lymphoma, Large B-Cell, Diffuse - diagnostic imaging | Lymphoma, Large-Cell, Anaplastic - diagnosis | Liver - diagnostic imaging | Aged, 80 and over | Adult | Female | Retrospective Studies | Lung - pathology | Lymphoma, T-Cell, Peripheral - drug therapy | Lymphoma, Large B-Cell, Diffuse - drug therapy | Antineoplastic Combined Chemotherapy Protocols | Lymphoma, Large-Cell, Anaplastic - mortality | Lymphoma, Large B-Cell, Diffuse - mortality | Lymphoma, Large B-Cell, Diffuse - diagnosis | Lymphoma, T-Cell, Peripheral - diagnosis | Lymphoma, Large-Cell, Anaplastic - drug therapy | Adolescent | Survival Analysis | Vincristine - therapeutic use | Fluorodeoxyglucose F18 | Aged | Neoplasm Staging | Lymphoma, T-Cell, Peripheral - mortality | Care and treatment | Non-Hodgkin's lymphomas | PET imaging | T cells
Journal Article
Journal Article
British Journal of Haematology, ISSN 0007-1048, 04/2016, Volume 173, Issue 2, pp. 236 - 244
Journal Article